English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Background  Biomarkers are needed to individualize cancer radiation treatment. Therefore, we have investigated the association between various risk factors, including single nucleotide polymorphisms (SNPs) in candidate genes and late complications to radiotherapy in our nasopharyngeal cancer patients.    Methods  A cohort of 155 patients was included. Normal tissue fibrosis was scored using RTOG/EORTC grading system. A total of 45 SNPs in 11 candidate genes ( ATM ,  XRCC1 ,  XRCC3 ,  XRCC4 ,  XRCC5 ,  PRKDC ,  LIG4 ,  TP53 ,  HDM2 ,  CDKN1A ,  TGFB1 ) were genotyped by direct genomic DNA sequencing. Patients with severe fibrosis (cases, G3-4,  n  = 48) were compared to controls (G0-2,  n  = 107).    Results  Univariate analysis showed significant association ( P  < 0.05) with radiation complications for 6 SNPs ( ATM  G/A rs1801516,  HDM2  promoter T/G rs2279744 and T/A rs1196333,  XRCC1  G/A rs25487,  XRCC5  T/C rs1051677 and  TGFB1  C/T rs1800469). In addition, Kaplan-Meier analyses have also highlighted significant association between genotypes and length of patients’ follow-up after radiotherapy. Multivariate logistic regression has further sustained these results suggesting predictive and prognostic roles of SNPs.    Conclusions  Univariate and multivariate analysis suggest that radiation toxicity in radiotherapy patients are associated with certain SNPs, in genes including  HDM2  promoter studied for the 1st time. These results support the use of SNPs as genetic predictive markers for clinical radiosensitivity and evoke a prognostic role for length of patients’ follow-up after radiotherapy.

radiation oncology

RETRACTED ARTICLE: SNPs in genes implicated in radiation response are associated with radiotoxicity and evoke roles as predictive and prognostic biomarkers